share_log

Maxim Group Initiates Coverage On Helius Medical Tech With Buy Rating, Announces Price Target of $1

Benzinga Real-time News ·  Dec 20, 2022 08:48

Maxim Group analyst Anthony Vendetti initiates coverage on Helius Medical Tech (NASDAQ:HSDT) with a Buy rating and announces Price Target of $1.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment